These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 2248211)

  • 41. Angiotensin converting enzyme inhibition. Systemic and regional hemodynamics in rats and humans.
    Giudicelli JF; Richer C; Richard C; Thuillez C
    Am J Hypertens; 1991 Mar; 4(3 Pt 2):258S-262S. PubMed ID: 2043315
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of vasodilators on the coronary circulation in congestive heart failure.
    Kiowski W; Burkart F
    Am J Cardiol; 1988 Sep; 62(8):99E-103E. PubMed ID: 2970786
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reduced exercise tolerance in chronic heart failure and its relationship to neurohumoral factors.
    Drexler H
    Eur Heart J; 1991 Aug; 12 Suppl C():21-8. PubMed ID: 1680684
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Benefits of prolonged angiotensin-converting enzyme inhibition in congestive heart failure.
    Giles TD
    Cardiology; 1991; 79 Suppl 1():16-21. PubMed ID: 1680559
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparative effects of carvedilol and metoprolol on regional vascular responses to adrenergic stimuli in normal subjects and patients with chronic heart failure.
    Hryniewicz K; Androne AS; Hudaihed A; Katz SD
    Circulation; 2003 Aug; 108(8):971-6. PubMed ID: 12912816
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Skeletal muscle function, morphology, and metabolism in patients with congestive heart failure.
    Minotti JR; Christoph I; Massie BM
    Chest; 1992 May; 101(5 Suppl):333S-339S. PubMed ID: 1576861
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Influence of medical treatments on the functional status in patients with chronic cardiac insufficiency].
    Cohen-Solal A; Laperche T; Gourgon R
    Arch Mal Coeur Vaiss; 1990 Nov; 83(13):1953-5. PubMed ID: 2125415
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The central and regional cardiovascular responses to intravenous and intracoronary administration of the phenyldihydropyridine elgodipine in anaesthetized pigs.
    Sassen LM; Soei LK; Koning MM; Verdouw PD
    Br J Pharmacol; 1990 Feb; 99(2):355-63. PubMed ID: 2328400
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Pathophysiology of heart failure: peripheral vascular and muscular mechanisms].
    Kiowski W
    Ther Umsch; 1993 Jun; 50(6):394-400. PubMed ID: 8351668
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Nifedipine in congestive heart failure: effects on resting and exercise hemodynamics and regional blood flow.
    Leier CV; Patrick TJ; Hermiller J; Pacht KD; Huss P; Magorien RD; Unverferth DV
    Am Heart J; 1984 Dec; 108(6):1461-8. PubMed ID: 6507242
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Congestive heart failure--pathophysiology and medical treatment.
    Remme WJ
    J Cardiovasc Pharmacol; 1986; 8 Suppl 1():S36-52. PubMed ID: 2422492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Angiotensin converting enzyme inhibition, AT1 receptor inhibition, and combination therapy with pacing induced heart failure: effects on left ventricular performance and regional blood flow patterns.
    Krombach RS; Clair MJ; Hendrick JW; Houck WV; Zellner JL; Kribbs SB; Whitebread S; Mukherjee R; de Gasparo M; Spinale FG
    Cardiovasc Res; 1998 Jun; 38(3):631-45. PubMed ID: 9747431
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
    Cruden NL; Witherow FN; Webb DJ; Fox KA; Newby DE
    Arterioscler Thromb Vasc Biol; 2004 Jun; 24(6):1043-8. PubMed ID: 15105283
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure.
    Packer M; Medina N; Yushak M
    Circulation; 1984 Dec; 70(6):1038-47. PubMed ID: 6388899
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hemodynamic determinants of exercise capacity in chronic heart failure.
    Myers J; Froelicher VF
    Ann Intern Med; 1991 Sep; 115(5):377-86. PubMed ID: 1863029
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Regional blood flow effects of dopexamine versus enalaprilat during propofol anaesthesia in rabbits with experimental chronic heart failure.
    Blake DW; Way D; Trigg L; McGrath BP
    Cardiovasc Res; 1994 May; 28(5):710-4. PubMed ID: 8025917
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vasodilator therapy for congestive heart failure. Lessons from mortality trials.
    Groden DL
    Arch Intern Med; 1993 Feb; 153(4):445-54. PubMed ID: 8435024
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sympathetic activity and regional blood flow in heart failure.
    Dargie H
    Eur Heart J; 1990 Apr; 11 Suppl A():39-43. PubMed ID: 2188837
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Methods for evaluating vasodilator agents in cardiac failure].
    Dahan M
    Arch Mal Coeur Vaiss; 1990 Mar; 83 Spec No 2():63-7. PubMed ID: 2111689
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Allopurinol improves endothelial dysfunction in chronic heart failure.
    Farquharson CA; Butler R; Hill A; Belch JJ; Struthers AD
    Circulation; 2002 Jul; 106(2):221-6. PubMed ID: 12105162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.